GLP1R and type 2 diabetes mellitus: Locally, we have seen an increased burden of T2DM in youth [10], and we aimed to evaluate the effectiveness of both on‐ and off‐label GLP‐1 receptor agonists in paediatric patients with T2DM in a real‐world setting.